Spinal Nerve Piriform Plexus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Spinal Nerve Piriform Plexus refers to the intricate network of nerve fibers that emerge from the spinal cord and interweave to form the peripheral nerves supplying the body. This complex plexus represents a critical intersection between the central nervous system (CNS) and the peripheral nervous system (PNS), facilitating somatosensory perception, motor control, and autonomic regulation.
The spinal nerves emerge from the spinal cord through the intervertebral foramina as combined sensory (dorsal root) and motor (ventral root) fibers. These fibers then reorganize into the characteristic plexiform patterns that give rise to the named peripheral nerves. The piriform (literally pear-shaped) arrangement describes the typical branching pattern where nerves radiate outward from a common point like fibers from a pear core.
The spinal nerve fibers mix and redistribute in a characteristic pattern:
The spinal nerve plexus transmits:
Peripheral nerves arising from the plexus supply:
Damage to spinal nerve roots or peripheral nerves can cause:
Long-standing diabetes commonly affects:
CIDP involves:
Treatment approaches include:
The study of Spinal Nerve Piriform Plexus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet. 2011;377(9760):1925-1937. DOI:10.1016/S0140-6736(1061176-4
[2] Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5-20. DOI:10.1007/s10654-015-0094-4
[3] Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62(4):310-318. DOI:10.1136/jnnp.62.4.310
[4] England JD, Gronseth GS, Franklin G, et al. Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing. Neurology. 2009;72(2):185-192. DOI:10.1212/01.wnl.0000336370.54210.6d
[5] Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002. DOI:10.1038/nrdp.2017.2
[6] Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521-534. DOI:10.1016/S1474-4422(1270065-0
[7] Rajabally Y, Stettner M, Kieseier BC, Hartung HP, Cysique LA. CIDP and other inflammatory neuropathies in diabetes - prevalence and functional impact. Neurology. 2020;94(1):e100-e108. DOI:10.1212/WNL.0000000000008947
[8] Wolfe GI, Triggs WJ, Nations SK, Daube JR. Electrodiagnostic findings in inflammatory demyelinating polyneuropathy. J Clin Neurophysiol. 2011;28(3):277-285. DOI:10.1097/WNP.0b013e31821c2d87